Comparison of toxicity and outcome in patients with acute myeloid leukemia treated with high-dose cytosine arabinoside consolidation after induction with a regimen containing idarubicin or daunorubicin.

Source:http://linkedlifedata.com/resource/pubmed/id/9619732

Download in:

View as

General Info

PMID
9619732